Alcon AG (ALC) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Based on the latest financial reports, Alcon AG (ALC) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF661.33 Million ≈ $836.10 Million USD) by net assets (CHF22.02 Billion ≈ $27.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALC cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Alcon AG - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Alcon AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Alcon AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alcon AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Coal India Limited
NSE:COALINDIA
0.083x
VICI Properties Inc
NYSE:VICI
0.022x
Grupo Financiero Banorte S.A.B. de C.V
MX:GFNORTEO
-0.031x
Sunbelt Rentals Holdings, Inc.
NYSE:SUNB
0.208x
Bajaj Auto Limited
NSE:BAJAJ-AUTO
-0.006x
Ares Management LP
NYSE:ARES
0.048x
Prudential plc
F:PRU2
0.030x
Viking Holdings Ltd
NYSE:VIK
0.742x

Annual Cash Flow Conversion Efficiency for Alcon AG (2015–2025)

The table below shows the annual cash flow conversion efficiency of Alcon AG from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see ALC company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF22.02 Billion
≈ $27.84 Billion
CHF2.38 Billion
≈ $3.01 Billion
0.108x +12.11%
2024-12-31 CHF21.55 Billion
≈ $27.25 Billion
CHF2.08 Billion
≈ $2.63 Billion
0.096x +43.19%
2023-12-31 CHF20.62 Billion
≈ $26.07 Billion
CHF1.39 Billion
≈ $1.75 Billion
0.067x +8.81%
2022-12-31 CHF19.68 Billion
≈ $24.88 Billion
CHF1.22 Billion
≈ $1.54 Billion
0.062x -11.45%
2021-12-31 CHF19.26 Billion
≈ $24.34 Billion
CHF1.34 Billion
≈ $1.70 Billion
0.070x +59.74%
2020-12-31 CHF18.82 Billion
≈ $23.80 Billion
CHF823.00 Million
≈ $1.04 Billion
0.044x -8.26%
2019-12-31 CHF19.30 Billion
≈ $24.40 Billion
CHF920.00 Million
≈ $1.16 Billion
0.048x -18.41%
2018-12-31 CHF19.52 Billion
≈ $24.67 Billion
CHF1.14 Billion
≈ $1.44 Billion
0.058x +10.45%
2017-12-31 CHF23.03 Billion
≈ $29.11 Billion
CHF1.22 Billion
≈ $1.54 Billion
0.053x -2.24%
2016-12-31 CHF23.01 Billion
≈ $29.09 Billion
CHF1.25 Billion
≈ $1.57 Billion
0.054x -6.66%
2015-12-31 CHF23.64 Billion
≈ $29.88 Billion
CHF1.37 Billion
≈ $1.73 Billion
0.058x --

About Alcon AG

SW:ALC Switzerland Medical Instruments & Supplies
Market Cap
$32.36 Billion
CHF25.60 Billion CHF
Market Cap Rank
#898 Global
#15 in Switzerland
Share Price
CHF52.52
Change (1 day)
-0.64%
52-Week Range
CHF48.75 - CHF73.62
All Time High
CHF84.68
About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other product… Read more